Algeria
Diabetes country report 2011 — 2050
Skip Map
Number of adults (20–79 years) with diabetes in Algeria (DZ)
| 2011 | 1.4 million |
| 2024 | 4.8 million |
| 2050 | 7.9 million |
Algeria is one of the 21 countries and territories in the IDF Middle-East and North Africa Region. Algeria has the fifth highest number of adults (20-79 years) with diabetes in the Region.
Data source(s) used for the diabetes estimates in adults:
- Ministère de la Santé, de la Population et de la Reforme Hospitalière, REPUBLIQUE ALGERIENNE DEMOCRATIQUE ET POPULAIRE, WHO STEPS, 2016
2000
2011
2024
2050
Loading...
| Diabetes estimates (20-79 y) | ||||
|---|---|---|---|---|
| People with diabetes, in 1,000s | - | 1,435.1 | 4,761.8 | 7,936.9 |
| Age-standardised prevalence of diabetes, % | - | 7.0 | 17.5 | 19.3 |
| Proportion of people with undiagnosed diabetes, % | - | - | 31.7 | - |
| People with undiagnosed diabetes, in 1,000s | - | 883.6 | 1,509.0 | - |
| Impaired Fasting Glucose (IFG) | ||||
|---|---|---|---|---|
| People with IFG, in 1,000s | - | - | 1,896.2 | 2,949.3 |
| Age-standardised prevalence of IFG, % | - | - | 6.8 | 7.2 |
| Impaired Glucose Tolerance (IGT) | ||||
|---|---|---|---|---|
| People with IGT, in 1,000s | - | 1,186.8 | 1,816.9 | 2,813.8 |
| Age-standardised prevalence of IGT, % | - | 5.7 | 6.5 | 6.9 |
| Mortality attributable to diabetes (20-79 y) | ||||
|---|---|---|---|---|
| Deaths attributable to diabetes | - | 9,395.0 | 20,642.0 | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 15.6 | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
|---|---|---|---|---|
| Live births affected by HIP | - | - | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
| Diabetes-related health expenditure | ||||
|---|---|---|---|---|
| Total diabetes-related health expenditure, USD million | - | - | 3,111.2 | 4,390.6 |
| Total diabetes-related health expenditure, ID million | - | - | 11,705.9 | 16,519.8 |
| Diabetes-related health expenditure per person, USD | - | 415.0 | 653.4 | 553.2 |
| Diabetes-related health expenditure per person, ID | - | - | 2,458.3 | 2,081.4 |
| Type 1 diabetes estimates in children and adolescents | ||||
|---|---|---|---|---|
| People with type 1 diabetes (all age groups) | - | - | 188,195.0 | - |
| People with type 1 diabetes (0-19 y) | - | - | 56,161.6 | - |
| Demographics | ||||
|---|---|---|---|---|
| Total adult population (20-79 y), in 1,000s | - | 22,619.9 | 28,219.3 | 41,401.6 |
| Population of children and adolescents (0-19 y) | - | - | 17,856,648.0 | - |
Loading...
| Diabetes estimates (20-79 y) | |
|---|---|
| People with diabetes, in 1,000s | - |
| Age-standardised prevalence of diabetes, % | - |
| Proportion of people with undiagnosed diabetes, % | - |
| People with undiagnosed diabetes, in 1,000s | - |
| Impaired Fasting Glucose (IFG) | |
|---|---|
| People with IFG, in 1,000s | - |
| Age-standardised prevalence of IFG, % | - |
| Impaired Glucose Tolerance (IGT) | |
|---|---|
| People with IGT, in 1,000s | - |
| Age-standardised prevalence of IGT, % | - |
| Mortality attributable to diabetes (20-79 y) | |
|---|---|
| Deaths attributable to diabetes | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
|---|---|
| Live births affected by HIP | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - |
| Live births affected by other types of diabetes first detected in pregnancy | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - |
| Diabetes-related health expenditure | |
|---|---|
| Total diabetes-related health expenditure, USD million | - |
| Total diabetes-related health expenditure, ID million | - |
| Diabetes-related health expenditure per person, USD | - |
| Diabetes-related health expenditure per person, ID | - |
| Type 1 diabetes estimates in children and adolescents | |
|---|---|
| People with type 1 diabetes (all age groups) | - |
| People with type 1 diabetes (0-19 y) | - |
| Demographics | |
|---|---|
| Total adult population (20-79 y), in 1,000s | - |
| Population of children and adolescents (0-19 y) | - |
